CarepathRx has acquired the management services organizations that operate UPMC’s Chartwell Pennsylvania LP infusion medicine subsidiary for $400 million while the Pittsburgh-based health care giant becomes a strategic investor in Mercer Island, Washington-based CarepathRx.
Other financial terms of the deal, which was announced Tuesday and is expected to close in 30 days, were not disclosed.
Cantor Fitzgerald & Co. served as financial advisor to Chartwell in forming the management services organization and the new partnership with CarepathRx.
CarepathRx was founded in 2019 and the company helps patients who are undergoing complicated medication therapies. Oakdale-based Chartwell, a home infusion and specialty pharmacy company, was founded in 1991.
Kris B. Mamula:kmamula@post-gazette.com or 412-263-1699






Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.